NASDAQ: RPTX
Repare Therapeutics Inc Stock Ownership - Who owns Repare Therapeutics?

Insider buying vs selling

Have Repare Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Steve ForteEVP CHIEF FINANCIAL OFFICER2025-03-126,884$1.14
$7.85kSell
Maria KoehlerEVP CHIEF MEDICAL OFFICER2025-03-123,596$1.14
$4.10kSell
Lloyd Mitchell SegalPRESIDENT AND CEO2025-03-1221,179$1.14
$24.14kSell
Michael ZindaEVP CHIEF SCIENTIFIC OFFICER2025-03-125,611$1.14
$6.40kSell

1 of 1

RPTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RPTX insiders and whales buy or sell their stock.

RPTX Shareholders

What type of owners hold Repare Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ansbert Gadicke9.05%3,882,485$6.56MInsider
Davis Jerel8.57%3,675,793$6.21MInsider
Versant Ventures V LLC8.51%3,650,662$6.17MInsider
Versant Vantage I LP8.51%3,650,662$6.17MInsider
Blue Owl Capital Holdings LP8.03%3,443,659$5.82MInstitution
Mpm Bioventures 2014 LP7.00%3,003,772$5.08MInsider
Versant Venture Management LLC6.17%2,646,657$4.47MInstitution
Todd Foley5.23%2,242,636$3.79MInsider
Redmile Group LLC3.70%1,586,174$2.68MInsider
Bvf Partners L P1.28%548,938$927.71kInsider

1 of 3

RPTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RPTX14.96%54.27%Net Selling
ACRV3.89%47.07%Net SellingNet Selling
ABVC2.11%86.53%
CRVO0.89%99.11%Net BuyingNet Buying
COEP0.61%99.39%

Repare Therapeutics Stock Ownership FAQ

Who owns Repare Therapeutics?

Repare Therapeutics (NASDAQ: RPTX) is owned by 14.96% institutional shareholders, 54.27% Repare Therapeutics insiders, and 30.78% retail investors. Ansbert Gadicke is the largest individual Repare Therapeutics shareholder, owning 3.88M shares representing 9.05% of the company. Ansbert Gadicke's Repare Therapeutics shares are currently valued at $6.41M.

If you're new to stock investing, here's how to buy Repare Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.